Eribulin Mesylate 40033-0364-01

Package NDC

40033-0364-01

Manufacturer: Kindos Pharmaceuticals Co., Ltd.
Dosage Form: Injection
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: August 5, 2025
Listing Expires: December 31, 2026
Application: ANDA218142

Need to source Eribulin Mesylate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Eribulin Mesylate	.5 mg/mL

Drug Class

Microtubule Inhibition [PE]Microtubule Inhibitor [EPC]

Selected Package

40033-0364-01Selected

1 VIAL, SINGLE-DOSE in 1 CARTON (40033-364-01) / 2 mL in 1 VIAL, SINGLE-DOSE